This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its unique spirocyclic structure makes it a valuable intermediate in the creation of molecules targeting neurological disorders, such as anxiety, depression, and other central nervous system conditions. Additionally, it is explored for its potential in modulating specific receptors or enzymes involved in disease pathways. The methanesulfonate salt form enhances its solubility, making it more suitable for formulation studies and biological testing. Researchers also investigate its role in improving the pharmacokinetic properties of drug molecules, such as bioavailability and stability.